Development of mIBG as a Cardiac Innervation Imaging Agent

JACC: Cardiovascular Imaging

Volumn 3, Issue 1, 2010, Pages 111-116

  Raffel, David M ^a   Wieland, Donald M ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

norepinephrine transporter; radiopharmaceuticals; sympathetic nervous system

Indexed keywords

(3 IODOBENZYL)GUANIDINE; (3 IODOBENZYL)GUANIDINE I 131; 2 IODOBENZYLGUANIDINE I 125; 3 HYDROXYEPHEDRINE C 11; 4 IODOBENZYLGUANIDINE I 125; 6 BETA IODOMETHYL 19 NORCHOLESTEROL I 123; 6 FLUOROMETARAMINOL F 18; ADRENALIN C 11; ANTIARRHYTHMIC AGENT; BRETYLIUM; CARBON 14; DOPAMINE; IODINE 123; IODO 19 CHOLESTEROL I 123; NORADRENALIN; PHENYLEPHRINE C 11; RADIOACTIVE IODINE; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADRENAL CORTEX; ADRENAL MEDULLA; ARTICLE; HEART INFARCTION; HEART INNERVATION; HEART PERFUSION; HEART SCINTISCANNING; HUMAN; IMAGE DISPLAY; IMAGE PROCESSING; ISOTOPE LABELING; NERVE INJURY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; SYMPATHETIC INNERVATION; SYMPATHETIC NERVE; TOMOGRAPHY;

3-IODOBENZYLGUANIDINE; ANIMALS; HEART; HEART DISEASES; HISTORY, 20TH CENTURY; HISTORY, 21ST CENTURY; HUMANS; PREDICTIVE VALUE OF TESTS; RADIOPHARMACEUTICALS; SYMPATHETIC NERVOUS SYSTEM; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 73649113185     PISSN: 1936878X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jcmg.2009.09.015     Document Type: Article

References (38)

1. Sisson J.C. Radiopharmaceuticals for nuclear endocrinology at the University of Michigan. Cancer Biother Radiopharm 15 (2000) 305-318
2. Blair R.J., Beierwaltes W.H., Lieberman L.M., et al. Radiolabeled cholesterol as an adrenal scanning agent. J Nucl Med 12 (1971) 176-182
3. Basmadjian G.P., Hetzel K.R., Ice R.D., and Beierwaltes W.H. Synthesis of a new adrenal cortex imaging agent 6-β-131I-iodomethyl-19-norcholesterol-5(10)-en-3β-ol (NP-59). J Labelled Comp Radiopharm 11 (1975) 427-434
4. Morales J.O., Beierwaltes W.H., Counsell R.E., and Meier D.H. The concentration of radioactivity from labeled epinephrine and its precursors in the dog adrenal medulla. J Nucl Med 8 (1967) 800-809
5. Lebowitz E., Greene M.W., Fairchild R., et al. Thallium-201 for medical use. I. J Nucl Med 16 (1975) 151-155
6. Counsell R.E., Yu T., Ranade V.V., and Buswink A. Potential organ- or tumor-imaging agents. 14. Myocardial scanning agents. J Med Chem 16 (1973) 1038-1040
7. Counsell R.E., Yu T., Ranade V.V., Buswink A., Carr E.A., and Carroll M. Radioiodinated bretylium analogs for myocardial scanning. J Nucl Med 15 (1974) 991-996
8. Korn N., Buswink A., Yu T., Carr E.A., Carroll M., and Counsell R.E. A radioiodinated bretylium analog as a potential agent for scanning the adrenal medulla. J Nucl Med 18 (1977) 87-89
9. Ice R.D., Wieland D.M., Beierwaltes W.H., Lawton R.G., and Redmond M.J. Concentration of dopamine analogs in the adrenal medulla. J Nucl Med 16 (1975) 1147-1151
10. Beierwaltes W.H., Wieland D.M., Ice R.D., et al. Localization of radiolabeled enyzme inhibitors in the adrenal gland. J Nucl Med 17 (1976) 998-1002
11. Beierwaltes W.H., Wieland D.M., Mosley S.T., et al. Imaging the adrenal glands with radiolabeled inhibitors of enzymes: concise communication. J Nucl Med 19 (1978) 200-203
12. Boura A.L.A., Copp F.C., and Green A.F. New antiadrenergic compounds. Nature 184 (1959) 70-71
13. Wieland D.M., Swanson D.P., Brown L.E., and Beierwaltes W.H. Imaging the adrenal medulla with an I-131-labeled antiadrenergic agent. J Nucl Med 20 (1979) 155-158
14. Short J.H., and Darby T.D. Sympathetic nervous system blocking agents. III. Derivatives of benzylguanidine. J Med Chem 10 (1967) 833-840
15. Wieland D.M., Mangner T.J., Inbasekaran M.N., Brown L.E., and Wu J. Adrenal medulla imaging agents: a structure-distribution relationship study of radiolabeled aralkylguanidines. J Med Chem 27 (1984) 149-155
16. Vogel R.A., Kirch D., LeFree M., and Steele P. A new method of multiplanar emission tomography using a seven pinhole collimator and an Anger scintillation camera. J Nucl Med 19 (1978) 648-654
17. Rogers W.L., Koral K.F., Mayans R., et al. Coded-aperture imaging of the heart. J Nucl Med 21 (1980) 371-378
18. 131I]iodobenzylguanidine. J Nucl Med 21 (1980) 349-353
19. Wieland D.M., Brown L.E., Rogers W.L., et al. Myocardial imaging with a radioiodinated norepinephrine storage analog. J Nucl Med 22 (1981) 22-31
20. Kline R.C., Swanson D.P., Wieland D.M., et al. Myocardial imaging in man with I-123 meta-iodobenzylguanidine. J Nucl Med 22 (1981) 129-132
21. Mangner T.J., Wu J., and Wieland D.M. Solid-phase exchange radioiodination of aryl iodides. Facilitation by ammonium sulfate. J Org Chem 47 (1982) 1484-1488
22. Sisson J.C., Frager M.S., Valk T.W., et al. Scintigraphic localization of pheochromocytoma. N Engl J Med 305 (1981) 12-17
23. Sisson J., Shapiro B., Beierwaltes W.H., et al. Treatment of malignant pheochromocytoma with a new radiopharmaceutical. Trans Assoc Am Physicians 96 (1983) 209-217
24. 131I]iodobenzylguanidine (I-131 MIBG) and circulating catecholamines in suspected pheochromocytoma. J Nucl Med 24 (1983) 1127-1134
25. Manger W.M., and Hoffman B.B. Heart imaging in the diagnosis of pheochromocytoma and assessment of catecholamine uptake. J Nucl Med 24 (1983) 1194-1196
26. Jaques S., Tobes M.C., Sisson J.C., Baker J.A., and Wieland D.M. Comparison of the sodium dependency of uptake of meta-iodobenzylguanidine and norepinephrine into cultured bovine adrenomedullary cells. Mol Pharmacol 26 (1984) 539-546
27. Tobes M.C., Jaques S., Wieland D.M., and Sisson J.C. Effect of uptake-one inhibitors on the uptake of norepinephrine and metaiodobenzylguanidine. J Nucl Med 26 (1985) 897-907
28. Sisson J.C., Wieland D.M., Sherman P., Mangner T.J., Tobes M.C., and Jacques Jr. S. Metaiodobenzylguanidine as an index of the adrenergic nervous system integrity and function. J Nucl Med 28 (1987) 1620-1624
29. Nakajo M., Shimabukuro K., Yoshimura H., et al. Iodine-131 metaiodobenzylguanidine intra- and extravesicular accumulation in the rat heart. J Nucl Med 27 (1986) 84-89
30. Sisson J., Shapiro B., Meyers L., et al. Metaiodobenzylguanidine to map scintigraphically the adrenergic nervous system in man. J Nucl Med 28 (1987) 1625-1636
31. Rabinovitch M.A., Rose C.P., Schwab A.J., et al. A method of dynamic analysis of iodine-123-meta-iodobenzylguanidine scintigrams in cardiac mechanical overload hypertrophy and failure. J Nucl Med 34 (1993) 589-600
32. Sisson J.C., Lynch J.J., Johnson J., et al. Scintigraphic detection of regional disruption of adrenergic neurons in the heart. Am Heart J 116 (1988) 67-76
33. Minardo J.D., Tuli M.M., Mock B.H., et al. Scintigraphic and electrophysiological evidence of canine myocardial sympathetic denervation and reinnervation produced by myocardial infarction or phenol application. Circulation 78 (1988) 1008-1019
34. 18F]fluorometaraminol. J Med Chem 33 (1990) 956-964
35. Schwaiger M., Kalff V., Rosenspire K., et al. Noninvasive evaluation of sympathetic nervous system in human heart by positron emission tomography. Circulation 82 (1990) 457-464
36. Raffel D.M., Corbett J.R., del Rosario R.B., et al. Clinical evaluation of carbon-11-phenylephrine: MAO sensitive marker of cardiac sympathetic neurons. J Nucl Med 37 (1996) 1923-1931
37. 11C]hydroxyephedrine and positron emission tomography. Circulation 101 (2000) 516-523
38. Raffel D.M., Jung Y.W., Gildersleeve D.L., et al. Radiolabeled phenethylguanidines: novel imaging agents for cardiac sympathetic neurons and adrenergic tumors. J Med Chem 50 (2007) 2078-2088